Nice

News

NICE okays NHS funding for MS and eczema drugs

The UK's NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in guidance for the multiple sclerosis and eczema drugs.

Views & Analysis

New NICE processes – same old problem?

Following two recent controversial public consultations, NICE recently updated its Guide to the Processes of Technology Appraisal.

News

NICE says 'no' to Roche's Perjeta after breast cancer surger...

NICE consulting on first draft decision

News

Patients call for end to two-year row over CF drug funding

UK patients are stepping up efforts to resolve the “heartbreaking” row that is denying their families access to Vertex’s groundbreaking cystic fibrosis (CF) drug Orkambi, after Sweden becam

News